About OptMed
OptMed is a company based in New York (United States) founded in 2007. OptMed has raised $3.78 million across 8 funding rounds. OptMed offers products and services including BlauProtect and SpectrumEX. OptMed operates in a competitive market with competitors including Neomend, Cohera Medical, Sealonix, GATT Technologies BV and Resivant Medical, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Optmed, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.78 M (USD)
in 8 rounds
-
Latest Funding Round
$200 K (USD), Series A
Jul 29, 2015
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OptMed
OptMed offers a comprehensive portfolio of products and services, including BlauProtect and SpectrumEX.
Protects intact and damaged skin with CE marking for EU use.
Adhesive for closing incisions with FDA clearance for medical applications.
Funding Insights of OptMed
OptMed has successfully raised a total of $3.78M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $200 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by OptMed
Investment portfolio details for OptMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OptMed
Detailed financials for OptMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optmed Comparisons
Peer comparison for OptMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OptMed
OptMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neomend, Cohera Medical, Sealonix, GATT Technologies BV and Resivant Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of air leak sealant for thoracic surgery
|
|
| Locked | Locked | Locked |
Develops innovative surgical adhesives and sealants for medical use.
|
|
| Locked | Locked | Locked |
Developer of hemostatic sealants for surgeries
|
|
| Locked | Locked | Locked |
Polymer-based adhesive tissue tape is developed for surgical sealants.
|
|
| Locked | Locked | Locked |
Surgical adhesives for topical skin closure are developed.
|
|
| Locked | Locked | Locked |
Wound closure solutions
|
Detailed competitors of OptMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optmed
Complete news archive for OptMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OptMed
OptMed was founded in 2007 and raised its 1st funding round 2 years after it was founded.
OptMed is headquartered in New York, United States. It is registered at New York, New York, United States.
OptMed is a funded company, having raised a total of $3.78M across 8 funding rounds to date.
OptMed was founded in 2007 in New York, United States, within the biotechnology sector. Biocompatible polymer platforms are developed for biosurgical adhesives, sealants, and industrial applications. Genitourinary therapeutic platforms are focused on treatments for lower urinary tract conditions, such as overactive bladder and kidney stones. Products like Devakor, a topical skin adhesive used in place of surgical sutures, are included in the portfolio. Operations emphasize commercialization of these medical technologies.
OptMed's top competitors include Neomend, GATT Technologies BV and Sealonix.
OptMed offers BlauProtect and SpectrumEX.